Dr Reddy’s Laboratories on Saturday mentioned it has launched within the US market a generic model of Sapropterin Dihydrochloride tablets which are used to deliver down blood phenylalanine (Phe) ranges in sufferers.
“We’re happy to launch this generic model of Sapropterin Dihydrochloride Tablets, for oral use, illustrating our continued dedication to deliver reasonably priced generic medicines to marketplace for sufferers,” Dr Reddy”s Laboratories Chief Government Officer, North America Generics, Marc Kikuchi, mentioned in an announcement.
This product demonstrates that the corporate is actively increasing the breadth of its portfolio with a therapy for a uncommon illness, he added.
“We’re happy to supply monetary help to sufferers by providing a co-pay card program for eligible sufferers, particulars will probably be out there on our web site,” Kikuchi mentioned.
The Hyderabad-based firm mentioned its Sapropterin Dihydrochloride tablets in 100 mg energy have been out there in bottle depend sizes of 120.
First Printed on Oct 3, 2020 01:25 pm